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RESEARCH NOTE
The Post Clinic Ambulatory Blood 
Pressure (PC-ABP) study correlates Post Clinic 
Blood Pressure (PCBP) with the gold standard 
Ambulatory Blood Pressure
Hunaina Shahab1, Hamza Sohail Khan1, Aysha Almas2, Mayera Tufail1, Khawar Abbas Kazmi1 
and Aamir Hameed Khan1*
Abstract 
Objective: Our previous study showed that post-clinic blood pressure (BP) taken 15 min after a physician–patient 
encounter was the lowest reading in a routine clinic. We aimed to validate this reading with 24 h Ambulatory Blood 
Pressure Monitoring (ABPM) readings. A cross-sectional study was conducted in the cardiology clinics at the Aga Khan 
University, Pakistan. Hypertensive patients aged ≥ 18 years, or those referred for the diagnosis of hypertension were 
included.
Results: Of 150 participants, 49% were males. 76% of all participants were hypertensive. Pre-clinic BP reading was 
measured by a nurse, in-clinic by a physician and 15 min post-clinic by a research assistant using a validated, auto-
mated BP device (Omron-HEM7221-E). All patients were referred for 24 h ABPM. Among the three readings taken dur-
ing a clinic visit, mean (± SD) systolic BP (SBP) pre-clinic, in-clinic, and 15 min post-clinic were 153.2 ± 23, 152.3 ± 21, 
and 140.0 ± 18 mmHg, respectively. Mean (± SD) diastolic BP (DBP) taken pre-clinic, in-clinic and 15 min post-clinic 
were 83.5 ± 12, 90.9 ± 12, and 86.4 ± 11 mmHg respectively. Mean (± SD) daytime ambulatory SBP, DBP and pulse 
readings were 134.7 ± 15, 78.7 ± 15 mmHg, and 72.6 ± 12/min, respectively. Pearson correlation coefficients of pre-
clinic, in-clinic and post-clinic SBP with daytime ambulatory-SBP were 0.4 (p value: < 0.001), 0.5 (p value: < 0.001) and 
0.6 (p value: < 0.001), respectively. Post-clinic BP has a good correlation with ambulatory BP and may be considered a 
more reliable reading in the clinic setting.
Keywords: Post-clinic blood pressure, Ambulatory Blood Pressure Monitoring, White-coat effect
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Introduction
Clinic blood pressure (BP) does not correlate well with 
24 h Ambulatory Blood Pressure Monitoring (ABPM) [1], 
and is unable to overcome white-coat effect [2]. National 
Institute for Health and Clinical Excellence in the United 
Kingdom has recommended the use of ABPM to confirm 
the diagnosis of hypertension [3]. However, the test is 
expensive [2] and in a developing country like Pakistan, 
many patients are unable to afford ABPM. It is also cum-
bersome, intolerable to a few patients, particularly during 
sleep [4], and requires expertise for analysis [5]. There-
fore it was important to investigate which BP reading 
measured in clinic came closest to the ABP reading.
Our preliminary work showed that the post-clinic sys-
tolic BP (SBP) reading taken 15 min after the physician’s 
encounter was 10  mmHg lower than the SBP reading 
taken in the clinic (p value < 0.001) [6]. We, therefore, 
conducted this study aiming to validate post-clinic BP 
(SBP and DBP) taken 15 min after the physician–patient 
encounter with 24 h ABPM.
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Main text
Methods
Study site, population, and definitions
A cross-sectional study was conducted in the outpatient 
cardiology clinics at the Aga Khan University Hospi-
tal, Pakistan, over a year and a half period starting 2015. 
Patients who were either hypertensive (defined as those 
with a clinic SBP ≥ 140 mmHg or DBP ≥ 90 mmHg [7]) 
or referred for the assessment of hypertension, aged 
≥ 18  years were recruited. Pregnant females, those 
with a history of volume loss or taking NSAIDs were 
excluded. White-coat hypertension was defined as clinic 
BP ≥ 140/90  mmHg with average ambulatory daytime 
BP < 135/85  mmHg [8]. White-coat effect was defined 
as clinic BP ≥ 20/10  mmHg higher than ambulatory BP 
[9]. Masked hypertension was defined as having a clinic 
BP < 140/90 mmHg and a daytime ABP ≥ 135/85 mmHg 
[10].
Clinic blood pressure measurement
BP and pulse readings were taken at three points in the 
clinic. The first BP and pulse reading of each participant 
was taken by the assessment nurse before the patient–
physician encounter as part of the clinic protocol i.e. pre-
clinic BP and pulse, after a waiting period (14 ± 1.2 min). 
The second reading was taken by the attending physician 
as part of the regular physical examination i.e. in-clinic 
BP and pulse after a waiting period (16 ± 1.4 min). This 
waiting time was inevitable due to the high patient num-
ber in every clinic and was applicable to each participant 
recruited in the study. Each participant was then asked to 
wait for 15 min in the regular waiting area (where smok-
ing and exertion was prohibited). They were then called 
back to another clinic room where the post-clinic BP and 
pulse reading was taken by a trained research assistant 
in the absence of the primary physician. An interval of 
15 min was chosen to replicate our previous study [6] and 
based on van der Wel et al’s study which showed that SBP 
reaches a plateau within the first 15  min in a clinic [2]. 
The remaining waiting period in the pre- and in-clinic 
setting matched the 15  min waiting period of the post-
clinic reading. At each of these three points, two BP and 
pulse readings were taken with 2  min interval between 
them and the average of the two was used in the final 
analysis.
For each BP reading, the participant was asked to sit 
with his/her back supported and feet on the floor; arm 
supported at the heart level; appropriate size cuff was 
applied (with the bladder covering 80% of the arm) [7]. 
We used an automated and validated [11] BP device 
(OMRON HEM 7221-E, M6 Comfort, Omron Health-
care Europe) to take all BP values to avoid all inter-user 
variability in the readings. At the start of the study, the 
nurse, physician and research associate were given a 
refresher training session in the appropriate method of 
taking BP to ensure that there was no variability in their 
methods of measuring BP.
Ambulatory Blood Pressure Measurement
After the post-clinic BP reading was taken, a 24 h ABPM 
monitor (SpaceLabs, model: 90217A) was attached to 
each participant which took BP and pulse readings every 
half hour during the daytime and every hour during the 
nighttime. Each patient was given a diary to record their 
activity throughout the test period. The test was consid-
ered valid when ≥ 85% readings were recorded [12].
The participants were asked to return to the clinic the 
next day after their 24  h of the ABPM were complete. 
Each participant was given a cash compensation for their 
travel and logistic expenses. If a discrepancy was detected 
between the BP taken during the clinic and the ABPM 
readings, the participant was scheduled for an early follow-
up visit. The participants were explained the side-effects of 
the ABPM test which included sleep disturbances, pain, 
skin irritation or bruising due to the cuff [13].
Statistical analysis
Statistical Package for Social Sciences (SPSS), version 23 
was used for analysis. Mean and standard deviation (SD) 
were used for quantitative variables, and frequency and 
percentages for categorical variables. For all three meas-
urement modalities, a mean was computed on the basis 
of all the measurements taken within each session. Pear-
son correlation coefficient was used to determine the 
correlation between post-clinic BP (SBP and DBP) and 
mean SBP and DBP recorded by the ABPM.
Sample size
Sample size calculation was based on the observed dif-
ferences in SBP between the in-clinic readings and 24 h 
ABPM readings from existing literature. A minimum 
sample size of 55 patients was required to show a mean 
difference of 27  mmHg between in-clinic SBP and day-
time ABPM record and a minimum sample size of 18 
was required to estimate a mean difference of 18 mmHg 
between in-clinic SBP and nighttime SBP, at an alpha 
of 5% and a beta of 80%. Assuming also that the mean 
difference between post-clinic BP (SBP and DBP) and 
24  h overall ambulatory BP (SBP and DBP) record 
with a power of 80% and a significance level of 5%, 
was 18  mmHg, a minimum sample of 123 patients was 
required. The sample size was further inflated by 20% 
up to 150 to account for non-responders. Keeping in 
account our clinic logistics and cost of conducting the 
study, a sample of 150 participants was convenient.
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Results
A total of 162 patients were approached to participate 
in the study. Nine participants refused as they were 
unable to return the ABPM apparatus next day. Three 
participants refused to carry the ABPM device to work 
the next morning. Of the 150 patients who consented to 
participate, 49% (n = 73) were males and 76% (n = 114) 
of all participants were hypertensive. The mean age of 
the participants was 60.3 ± 11.9 years. Of the 73 males, 
71% (n = 52) were hypertensive. Of the 77 females, 80% 
(n = 62) were hypertensive. Two percent (n = 3) of our 
participants had stage 2 chronic kidney disease, 8% 
(n = 12) were smokers, 20% (n = 30) had diabetes mel-
litus and 30% (n = 45) had coronary artery disease. 
Eleven (7.3%) of the participants reported the ABPM to 
interfere in their sleep. Five (3.3%) participants found 
the test uncomfortable. No major side effect was noted 
that required discontinuation of the process. Of the 
114 hypertensive participants, 43 (38%) had white-coat 
effect. Of the 36 participants who were referred for the 
assessment of hypertension, 25% (n = 9) had white-coat 
hypertension. Six percent (n = 9) participants experi-
enced masked hypertension.
The mean and standard deviation (± SD) SBP taken 
pre-clinic, in-clinic, 15  min post-clinic and 24  h over-
all ambulatory SBP is shown in Fig.  1a. The mean and 
standard deviation (± SD) DBP taken pre-clinic, in-clinic, 
15  min post-clinic and 24  h overall ambulatory DBP 
is shown in Fig.  1b. The mean and standard deviation 
(± SD) pulse taken pre-clinic, in-clinic, 15 min post-clinic 
and 24 h overall ambulatory pulse is shown in Fig. 1c.
The mean (± SD) 24  h overall ambulatory SBP, DBP 
and pulse readings were 130.9 ± 13, 74.8 ± 9 mmHg and 
70.7 ± 13/min, respectively. The mean (± SD) daytime 
ambulatory SBP, DBP and pulse readings were 134.7 ± 15, 
78.7 ± 15  mmHg and 72.6 ± 12/min, respectively. The 
mean (± SD) nighttime ambulatory SBP, DBP and pulse 
readings were 121.9 ± 18, 68.8 ± 9 and 63.8 ± 10 mmHg.
The Pearson correlation coefficient values of pre-clinic, 
in-clinic and 15  min post-clinic SBP with 24  h overall 
ambulatory, daytime ambulatory and nighttime ambula-
tory SBP are shown in Table 1.
The Pearson correlation coefficient values of pre-clinic, 
in-clinic and 15  min post-clinic DBP with 24  h overall 
ambulatory, daytime ambulatory and nighttime ambula-
tory DBP are shown in Table 2.
Discussion
We found that the BP reading taken 15  min after the 
clinic ended was the lowest reading of all taken in a real-
world clinic encounter and it came closest to the ABPM 
reading. Post-clinic SBP was about 12 mmHg lower than 
the reading taken in the presence of a physician, there-
fore, we think that the readings taken in the post-clinic 
time can help in alleviating the white-coat effect. Post-
clinic DBP was lower than the in-clinic DBP, however, the 
lowest was the pre-clinic DBP. These findings replicated 
the results of our previous study [6] therefore our results 
were noted to be reproducible. Our results were similar 
to Mancia et al’s study [14] which showed that patients’ 
BP and heart rate increased when visited by a physi-
cian or a nurse, the rise being higher with the physician. 
Both heart rate and BP declined, over the next 10  min, 
by about 10/5 mmHg owing to the reduction in the alert 
reaction [14]. Another study showed that serial auto-
mated office BP readings taken in a quiet room using the 
ABPM device decreased by about 12  mmHg to reach a 
plateau over 15 min and these readings remained similar 
at 30 min. This 30 min BP agreed well with the daytime 
ABPM [2]. Furthermore, our results also followed the 
same trend as the white coat hypertensive group in Oge-
degbe et al’s study [15] which showed that BP and anxi-
ety levels increased in the presence of a physician and 
then dropped after the physician had left the room, the 
rise being more dramatic in the white-coat hypertensive 
population [15].
We also found that the post-clinic BP correlated better 
with 24 h ambulatory BP and daytime BP as compared to 
pre-clinic or in-clinic BP. The correlation was stronger for 
SBP than for DBP. The difference between 24 h ambula-
tory SBP and post-clinic SBP was the lowest whereas it 
was the greatest between 24  h ambulatory SBP and in-
clinic SBP. Several investigations had attempted to seek 
an alternative to the 24 h ABPM. 6 and 10 h ABPM was 
comparable to daytime ABPM [16, 17]. Furthermore, the 
readings taken by an automated device in the absence of 
a physician were found to be more comparable to day-
time mean ABP readings [18]. However, to the best of 
our knowledge, the BP readings taken 15  min after the 
patients’ meeting with the physician had not been com-
pared to 24 h ABPM previously. Since post-clinic BP cor-
related better with ABPM readings, it may be considered 
as a surrogate for ABPM.
(See figure on next page.)
Fig. 1 a Trends of mean systolic blood pressure (SBP in mmHg) amongst participants, pre-clinic, in-clinic, 15-min post-clinic and 24 h overall 
ambulatory. b Trends in mean diastolic blood pressure (DBP in mmHg) amongst participants, pre-clinic, in-clinic, 15-min post-clinic and 24 h 
overall ambulatory. c Trends in mean pulse values (beats per minute) amongst participants, pre-clinic, in-clinic, 15-min post-clinic and 24 h overall 
ambulatory
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In clinical practice, office BP is used as a reference for 
diagnosis [19] and adjustment of antihypertensive medi-
cations. Our results highlighted the fact that prescribing 
medications based on in-clinic or pre-clinic BP read-
ings may result in an undesirable drop in BP. Post-clinic 
BP can be more reliable than the conventional methods 
as well as more cost-effective upfront in comparison to 
ABPM for assessment of hypertension and adjusting 
medications. It may also be used as an alternate when 
ABPM or home monitoring is not available.
ABPM, however, is superior to office BP due to its 
higher prognostic value [20]. It can assess nighttime BP 
which is a stronger predictor of cardiovascular morbid-
ity and mortality [21]. Further studies with a larger sam-
ple size are required to determine the prognostic value 
of post-clinic BP and its association with cardiovascular 
outcomes.
Conclusion
Post-clinic BP is the lowest reading taken in a clinic visit 
and has a good correlation with ambulatory BP. This 
reading may be more reliable for assessment of hyperten-
sion than in-clinic BP.
Limitations
  • This was a single-centered study conducted only in 
cardiology clinics limiting generalization in all set-
tings.
  • Post-clinic BP is a snapshot value taken during the 
day hence the dipper/non-dipper status cannot be 
accounted for by this reading.
  • We did not stratify our results according to age, 
therefore it is possible that different age groups may 
exhibit variation in results.
  • Three different individuals took BP readings which 
may have an implication on white-coat effect. This 
was done to replicate a real-world clinic scenario 
where BP readings are taken by different observers. 
All readings were taken using the validated auto-
mated BP device to minimize inter-observer variabil-
ity.
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Table 1 Correlation of pre-clinic, in-clinic, 15 min post-clinic SBP with ambulatory SBP readings
Pearson correlation coefficient Pre-clinic SBP In-clinic SBP 15 min post-clinic SBP
24 h overall ambulatory SBP 0.4 0.5 0.6
(p value: <0.001) (p value: < 0.001) (p value: < 0.001)
Daytime ambulatory SBP 0.4 0.5 0.6
(p value: <0.001) (p value: < 0.001) (p value: < 0.001)
Nighttime ambulatory SBP 0.3 0.4 0.4
(p value: 0.001) (p value: < 0.001) (p value: < 0.001)
Table 2 Correlation of pre-clinic, in-clinic, 15 min post-clinic DBP with ambulatory DBP readings
Pearson correlation coefficient Pre-clinic DBP In-clinic DBP 15 min post-clinic DBP
24 h overall ambulatory DBP 0.4 0.5 0.5
(p value: < 0.001) (p value: < 0.001) (p value: < 0.001)
Daytime ambulatory DBP 0.3 0.3 0.3
(p value: < 0.001) (p value: < 0.001) (p value: < 0.001)
Nighttime ambulatory DBP 0.3 0.4 0.3
(p value: 0.001) (p value: 0.000) (p value: < 0.001)
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